Gerlinde Vansant
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The LEDGIN GS-9822 inhibits HIV-2 infection and enhances HIV-2 latency.
Journal: Microbiology spectrum
Published: April 27, 2026
The HIV-2 OGH double reporter virus shows that HIV-2 is less cytotoxic and less sensitive to reactivation from latency than HIV-1 in cell culture.
Journal: Journal of virus eradication
Published: December 29, 2022
GS-9822, a preclinical LEDGIN candidate, displays a block-and-lock phenotype in cell culture.
Journal: Antimicrobial agents and chemotherapy
Published: February 23, 2021
The chromatin landscape at the HIV-1 provirus integration site determines viral expression.
Journal: Nucleic acids research
Published: May 10, 2020
Impact of LEDGIN treatment during virus production on residual HIV-1 transcription.
Journal: Retrovirology
Published: February 20, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026